Publikationen von 0000-0003-2039-8557
(ORCID: 0000-0003-2039-8557)

Mohty, Mohamad , Malard, Florent , Alaskar, Ahmed S., Aljurf, Mahmoud, Arat, Mutlu , Bader, Peter, Baron, Frederic, Bazarbachi, Ali , Blaise, Didier , Brissot, Eolia, Ciceri, Fabio, Corbacioglu, Selim , Dalle, Jean-Hugues, Dignan, Fiona, Huynh, Anne, Kenyon, Michelle, Nagler, Arnon, Pagliuca, Antonio, Perić, Zinaida, Richardson, Paul G., Ruggeri, Annalisa, Ruutu, Tapani, Yakoub-Agha, Ibrahim , Duarte, Rafael F. und Carreras, Enric (2023) Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplantation 58 (7), S. 749-754. Volltext nicht vorhanden.

Mohty, Mohamad, Malard, Florent, Abecasis, Manuel, Aerts, Erik, Alaskar, Ahmed S., Aljurf, Mahmoud, Arat, Mutlu , Bader, Peter, Baron, Frederic, Basak, Grzegorz, Bazarbachi, Ali, Blaise, Didier, Ciceri, Fabio, Corbacioglu, Selim, Dalle, Jean-Hugues, Dignan, Fiona, Fukuda, Takahiro, Huynh, Anne, Kuball, Jürgen, Lachance, Silvy, Lazarus, Hillard, Masszi, Tamas, Michallet, Mauricette, Nagler, Arnon, NiChonghaile, Mairead, Okamoto, Shinichiro, Pagliuca, Antonio, Peters, Christina, Petersen, Finn B., Richardson, Paul G., Ruutu, Tapani, Saber, Wael, Savani, Bipin N., Soiffer, Robert, Styczynski, Jan, Wallhult, Elisabeth, Yakoub-Agha, Ibrahim, Duarte, Rafael F. und Carreras, Enric (2020) Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transplantation 55 (3), S. 485-495. Volltext nicht vorhanden.

Passweg, Jakob R. , Baldomero, Helen, Basak, Grzegorz W., Chabannon, Christian , Corbacioglu, Selim, Duarte, Rafael, Kuball, Jürgen, Lankester, Arjan, Montoto, Silvia, de Latour, Régis Peffault, Snowden, John A., Styczynski, Jan, Yakoub-Agha, Ibrahim, Arat, Mutlu , Mohty, Mohamad und Kröger, Nicolaus (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplantation 54 (10), S. 1575-1585. Volltext nicht vorhanden.